NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 50 filers reported holding NIVALIS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $694,000 | +129.0% | 85,412 | +29.8% | 0.26% | +154.5% |
| Q2 2016 | $303,000 | +134.9% | 65,783 | +112.3% | 0.10% | +140.5% |
| Q1 2016 | $129,000 | -46.2% | 30,984 | 0.0% | 0.04% | -47.5% |
| Q4 2015 | $240,000 | -38.9% | 30,984 | +2.3% | 0.08% | -38.9% |
| Q3 2015 | $393,000 | -44.2% | 30,284 | -34.9% | 0.13% | -37.0% |
| Q2 2015 | $704,000 | – | 46,500 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|